Kose Tugba, Antal Arzu, Gunel Tuba
Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, 34134 Istanbul, Turkey.
Cardiovascular Surgery Clinic, Kartal Kosuyolu High Specialization Education and Research Hospital, 34865 Istanbul, Turkey.
Exp Ther Med. 2024 Jul 10;28(3):360. doi: 10.3892/etm.2024.12649. eCollection 2024 Sep.
Thoracic aortic dissection (TAD) is a highly lethal disease occurring inside the aortic wall and is characterized by matrix degradation. Matrix metalloproteinases (MMPs) are members of a large endopeptidase family that function in the degradation of the extracellular matrix (ECM) proteins, the maintenance of the ECM, and the regulation of signaling in the aorta. MMPs are found in tissue with their natural inhibitors. Tissue inhibitors of metalloproteinases (TIMPs) are actively involved in both the activation and inhibition of MMPs. The present study was designed to determine the mRNA level gene expression differences of and , which are considered to have an essential role in TAD, in aortic tissue and circulating monocyte cells. For the purpose of the present study, aortic vascular tissue and peripheral blood-derived monocyte cells were obtained from 10 patients with TAD and 10 control individuals. The gene expression levels of targeted genes ( and were examined by droplet digital PCR. In research results, decreased expression of and genes (P=0.043, P=0.009 and P=0.028, respectively) and increased ratio of (P=0.012) were obtained in the aortic tissue. No changes were observed in terms of gene expression in monocyte cells. When the results obtained were evaluated within the framework of TAD pathogenesis, it was concluded that expression changes in and genes may provide a sensitive environment in aortic tissue and may be associated with TAD formation. In addition, since the expression ratios of MMPs and TIMPs may reflect disease development, it was considered that the evaluation of MMPs along with TIMPs may be an appropriate and informative approach for future studies.
胸主动脉夹层(TAD)是一种发生在主动脉壁内的高致死性疾病,其特征为基质降解。基质金属蛋白酶(MMPs)是一个大型内肽酶家族的成员,在细胞外基质(ECM)蛋白降解、ECM维持以及主动脉信号调节中发挥作用。MMPs在组织中与其天然抑制剂一同存在。金属蛋白酶组织抑制剂(TIMPs)积极参与MMPs的激活和抑制过程。本研究旨在确定在主动脉组织和循环单核细胞中,被认为在TAD中起关键作用的MMPs和TIMPs的mRNA水平基因表达差异。为实现本研究目的,从10例TAD患者和10例对照个体获取了主动脉血管组织和外周血来源的单核细胞。通过液滴数字PCR检测靶向基因(MMPs和TIMPs)的基因表达水平。研究结果显示,在主动脉组织中,MMPs和TIMPs基因表达降低(分别为P = 0.043、P = 0.009和P = 0.028),而TIMP-1/TIMP-2比值升高(P = 0.012)。单核细胞中的基因表达未观察到变化。当在TAD发病机制框架内评估所得结果时,得出结论:MMPs和TIMPs基因的表达变化可能在主动脉组织中提供一个敏感环境,并可能与TAD形成相关。此外,由于MMPs和TIMPs的表达比值可能反映疾病发展,因此认为将MMPs与TIMPs一同评估可能是未来研究的一种合适且信息丰富的方法。